136 related articles for article (PubMed ID: 37316110)
1. Association of Beta-Blocker Therapy With Cardiovascular Outcomes in Patients With Stable Ischemic Heart Disease.
Godoy LC; Farkouh ME; Austin PC; Shah BR; Qiu F; Jackevicius CA; Wijeysundera HC; Krumholz HM; Ko DT
J Am Coll Cardiol; 2023 Jun; 81(24):2299-2311. PubMed ID: 37316110
[TBL] [Abstract][Full Text] [Related]
2. β-Blocker use and clinical outcomes in stable outpatients with and without coronary artery disease.
Bangalore S; Steg G; Deedwania P; Crowley K; Eagle KA; Goto S; Ohman EM; Cannon CP; Smith SC; Zeymer U; Hoffman EB; Messerli FH; Bhatt DL;
JAMA; 2012 Oct; 308(13):1340-9. PubMed ID: 23032550
[TBL] [Abstract][Full Text] [Related]
3. Association of β-blocker therapy with risks of adverse cardiovascular events and deaths in patients with ischemic heart disease undergoing noncardiac surgery: a Danish nationwide cohort study.
Andersson C; Mérie C; Jørgensen M; Gislason GH; Torp-Pedersen C; Overgaard C; Køber L; Jensen PF; Hlatky MA
JAMA Intern Med; 2014 Mar; 174(3):336-44. PubMed ID: 24247428
[TBL] [Abstract][Full Text] [Related]
4. Long-term impact of β-blocker in elderly patients without myocardial infarction after percutaneous coronary intervention.
Fukase T; Dohi T; Koike T; Yasuda H; Takeuchi M; Takahashi N; Chikata Y; Endo H; Doi S; Nishiyama H; Okai I; Iwata H; Okazaki S; Miyauchi K; Daida H; Minamino T
ESC Heart Fail; 2022 Feb; 9(1):545-554. PubMed ID: 34811932
[TBL] [Abstract][Full Text] [Related]
5. Perindopril and β-blocker for the prevention of cardiac events and mortality in stable coronary artery disease patients: A EUropean trial on Reduction Of cardiac events with Perindopril in stable coronary Artery disease (EUROPA) subanalysis.
Bertrand ME; Ferrari R; Remme WJ; Simoons ML; Fox KM
Am Heart J; 2015 Dec; 170(6):1092-8. PubMed ID: 26678630
[TBL] [Abstract][Full Text] [Related]
6. Association of beta-blocker treatment with mortality following myocardial infarction in patients with chronic obstructive pulmonary disease and heart failure or left ventricular dysfunction: a propensity matched-cohort analysis from the High-Risk Myocardial Infarction Database Initiative.
Coiro S; Girerd N; Rossignol P; Ferreira JP; Maggioni A; Pitt B; Tritto I; Ambrosio G; Dickstein K; Zannad F
Eur J Heart Fail; 2017 Feb; 19(2):271-279. PubMed ID: 27774703
[TBL] [Abstract][Full Text] [Related]
7. Beta-blockers in patients without heart failure after myocardial infarction.
Safi S; Sethi NJ; Korang SK; Nielsen EE; Feinberg J; Gluud C; Jakobsen JC
Cochrane Database Syst Rev; 2021 Nov; 11(11):CD012565. PubMed ID: 34739733
[TBL] [Abstract][Full Text] [Related]
8. β-blocker use in patients after percutaneous coronary interventions: one size fits all? Worse outcomes in patients without myocardial infarction or heart failure.
Ozasa N; Morimoto T; Bao B; Furukawa Y; Nakagawa Y; Kadota K; Iwabuchi M; Shizuta S; Shiomi H; Tazaki J; Natsuaki M; Kimura T;
Int J Cardiol; 2013 Sep; 168(2):774-9. PubMed ID: 23127614
[TBL] [Abstract][Full Text] [Related]
9. Predictors, Trends, and Outcomes (Among Older Patients ≥65 Years of Age) Associated With Beta-Blocker Use in Patients With Stable Angina Undergoing Elective Percutaneous Coronary Intervention: Insights From the NCDR Registry.
Motivala AA; Parikh V; Roe M; Dai D; Abbott JD; Prasad A; Mukherjee D
JACC Cardiovasc Interv; 2016 Aug; 9(16):1639-48. PubMed ID: 27539683
[TBL] [Abstract][Full Text] [Related]
10. Beta-blockers for suspected or diagnosed acute myocardial infarction.
Safi S; Sethi NJ; Nielsen EE; Feinberg J; Jakobsen JC; Gluud C
Cochrane Database Syst Rev; 2019 Dec; 12(12):CD012484. PubMed ID: 31845756
[TBL] [Abstract][Full Text] [Related]
11. Importance of Nonobstructive Coronary Artery Disease in the Prognosis of Patients With Heart Failure.
Braga JR; Austin PC; Ross HJ; Tu JV; Lee DS
JACC Heart Fail; 2019 Jun; 7(6):493-501. PubMed ID: 31078476
[TBL] [Abstract][Full Text] [Related]
12. Effect of beta-blocker therapy on mortality rates and future myocardial infarction rates in patients with coronary artery disease but no history of myocardial infarction or congestive heart failure.
Bunch TJ; Muhlestein JB; Bair TL; Renlund DG; Lappé DL; Jensen KR; Horne BD; Carter MA; Anderson JL;
Am J Cardiol; 2005 Apr; 95(7):827-31. PubMed ID: 15781009
[TBL] [Abstract][Full Text] [Related]
13. The effect of discontinuing beta-blockers after different treatment durations following acute myocardial infarction in optimally treated, stable patients without heart failure: a Danish, nationwide cohort study.
Halili A; Holt A; Eroglu TE; Haxha S; Zareini B; Torp-Pedersen C; Bang CN
Eur Heart J Cardiovasc Pharmacother; 2023 Sep; 9(6):553-561. PubMed ID: 37391361
[TBL] [Abstract][Full Text] [Related]
14. β-blockers, calcium antagonists, and mortality in stable coronary artery disease: an international cohort study.
Sorbets E; Steg PG; Young R; Danchin N; Greenlaw N; Ford I; Tendera M; Ferrari R; Merkely B; Parkhomenko A; Reid C; Tardif JC; Fox KM;
Eur Heart J; 2019 May; 40(18):1399-1407. PubMed ID: 30590529
[TBL] [Abstract][Full Text] [Related]
15. Heart rate control in an unselected consecutive population of outpatients with stable coronary artery disease: Analysis of the CARDIf Study Cohort.
Vitale C; Iellamo F; Volterrani M; Lombardi M; Fini M; Banach M; Rosano GM
Angiology; 2010 Nov; 61(8):763-7. PubMed ID: 20462892
[TBL] [Abstract][Full Text] [Related]
16. Relationship Between β-Blocker Therapy at Discharge and Clinical Outcomes in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.
Li C; Sun Y; Shen X; Yu T; Li Q; Ruan G; Zhang L; Huang Q; Zhuang H; Huang J; Ni L; Wang L; Jiang J; Wang Y; Wang DW
J Am Heart Assoc; 2016 Nov; 5(11):. PubMed ID: 27852588
[TBL] [Abstract][Full Text] [Related]
17. β-Blockers and Mortality After Acute Myocardial Infarction in Patients Without Heart Failure or Ventricular Dysfunction.
Dondo TB; Hall M; West RM; Jernberg T; Lindahl B; Bueno H; Danchin N; Deanfield JE; Hemingway H; Fox KAA; Timmis AD; Gale CP
J Am Coll Cardiol; 2017 Jun; 69(22):2710-2720. PubMed ID: 28571635
[TBL] [Abstract][Full Text] [Related]
18. Prognostic impact of ß-blocker use in patients with stable coronary artery disease.
Bauters C; Lemesle G; Meurice T; Tricot O; de Groote P; Lamblin N
Heart; 2014 Nov; 100(22):1757-61. PubMed ID: 24947319
[TBL] [Abstract][Full Text] [Related]
19. Medical Therapy for Secondary Prevention and Long-Term Outcome in Patients With Myocardial Infarction With Nonobstructive Coronary Artery Disease.
Lindahl B; Baron T; Erlinge D; Hadziosmanovic N; Nordenskjöld A; Gard A; Jernberg T
Circulation; 2017 Apr; 135(16):1481-1489. PubMed ID: 28179398
[TBL] [Abstract][Full Text] [Related]
20. Long-Term Beta-Blocker Therapy in Patients With Stable Coronary Artery Disease After Percutaneous Coronary Intervention.
Lee SJ; Choi DW; Kim C; Suh Y; Hong SJ; Ahn CM; Kim JS; Kim BK; Ko YG; Choi D; Park EC; Jang Y; Nam CM; Hong MK
Front Cardiovasc Med; 2022; 9():878003. PubMed ID: 35656394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
